Clinical Trial Update: A Study to Evaluate Adverse Events and Effectiveness of OnabotulinumtoxinA in Participants Undergoing Open Abdominal Ventral Hernia Repair for the Achievement of Primary Fascial Closure Without the Use of Component Separation Technique [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating the safety and effectiveness of onabotulinumtoxinA to aid primary fascial closure in open abdominal ventral hernia repair has been wi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Abdominal Hernia
• Ventral Hernia

Drugs mentioned

• OnabotulinumtoxinA (botulinum toxin type A)

Snippet

Sponsor: AbbVie | Conditions: Ventral Hernia, Abdominal Hernia | Phase 2 | Status: WITHDRAWN